Citation Tools

Download PDFPDF

Original research
Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial

Download to a citation manager

Cite this article as:
Panaccione R, Colombel J, Travis SPL, et al
Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial